Oruka Therapeutics
Price & Volume
Stats
See more52W Range | $5.49-$31 |
Market Cap | $1.4B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $0 |
News
See moreYahoo Finance • 20 days ago
Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Yahoo Finance • last month
Oruka Therapeutics to Present at Multiple November Investor Conferences
Yahoo Finance • 2 months ago
Barclays initiates coverage on U.S. small & mid-cap biotech stocks
Yahoo Finance • 2 months ago
Oruka Therapeutics files to sell 39.43M shares of common stock for holders
About
CEO | Dr. Lawrence Otto Klein Ph.D. |
Address | 855 Oak Grove Avenue, Menlo Park, CA, United States, 94025 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 28 |
